Cargando…
Advances in vitiligo: Update on therapeutic targets
Vitiligo, whose treatment remains a serious concern and challenge, is an autoimmune skin disease characterized by patches of depigmentation. The increasing application of molecular-targeted therapy in skin diseases, such as psoriasis and systemic lupus erythematosus, has dramatically improved their...
Autores principales: | Feng, Yifei, Lu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471423/ https://www.ncbi.nlm.nih.gov/pubmed/36119071 http://dx.doi.org/10.3389/fimmu.2022.986918 |
Ejemplares similares
-
Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response
por: Yang, Qianli, et al.
Publicado: (2021) -
Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective
por: Boniface, Katia, et al.
Publicado: (2021) -
Immunometabolism in the pathogenesis of vitiligo
por: Lyu, Chen, et al.
Publicado: (2022) -
Autoimmunity in Segmental Vitiligo
por: Speeckaert, Reinhart, et al.
Publicado: (2020) -
Translational Research in Vitiligo
por: Katz, Erica L., et al.
Publicado: (2021)